Compound ID | 1794
RX-04
Synonym(s): BV300
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the bacterial 50S ribosomal subunit |
| Target Pathogen: | Active against Enterobacteriaceae and Acinetobacter |
| Description: | Synthetic compound. Acquired from Melinta Therapeutics |
| Institute where first reported: | Bioversys AG (Melinta Therapeutics formerly Rib-X Pharmaceutical) |
| Year first mentioned: | 2018 |
| Development status: | Experimental |
| External links: | |
| Guide to Pharmacology: | RX-04A |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.